Latest News about Biotech
Recent news which mentions Biotech
Bristol Myers' German Partner Evotec Plans Layoffs, Cites 'Challenging Revenues, Profitability'
August 14, 2024
From Benzinga
Gene Editing Korro Bio's Preclinical Data 'Best-In-Class', Analyst Initiates With Outperform Rating
August 14, 2024
From Benzinga
Acelyrin Cuts Workforce, Deprioritizes Former Lead Drug Izokibep
August 14, 2024
From Benzinga
From Benzinga
From Benzinga
Tony Stark's Choice Vape? Synergy Innovation's Strategic Move To Restore Brands' Identity, Lead Market Niche
August 14, 2024
From Benzinga
Eli Lilly Smashed Estimates Thanks To Unbelievable Demand For Its Diabetes And Weight Loss Blockbusters
August 14, 2024
From Benzinga
Why Is Dermatology-Focused Verrica Pharmaceuticals Stock Trading Lower On Wednesday?
August 14, 2024
From Benzinga
From Benzinga
Artiva Biotherapeutics' Investigational Scalable Cell Therapies For Autoimmune Disorders, Analyst Initiate With Bullish Pitch
August 13, 2024
From Benzinga
New European Regulations Could Hinder Rare Disease Treatments, Pharma Industry Raises Concerns Over Stricter Clinical Trial Rules
August 13, 2024
From Benzinga
Long Covid Remains Diagnostic Mystery, Diagnosis Remains Elusive; National Institutes of Health-Funded Study Shows
August 13, 2024
From Benzinga
Why Is Penny Stock Apollomics Trading Higher On Tuesday?
August 13, 2024
From Benzinga
Chilecito: A Valley In The Andes That Defeated Mega-Mining And Embraced Sustainable Cannabis
August 13, 2024
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free